Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
780.68B | 776.87B | 824.77B | 727.40B | 552.18B | 526.00B | Gross Profit |
363.33B | 363.08B | 421.16B | 363.85B | 265.85B | 259.85B | EBIT |
192.47B | 196.23B | 258.20B | 227.86B | 153.35B | 146.25B | EBITDA |
225.09B | 286.09B | 283.97B | 248.42B | 171.94B | 162.92B | Net Income Common Stockholders |
174.88B | 178.32B | 224.61B | 192.99B | 121.79B | 110.50B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
511.29B | 511.29B | 623.50B | 697.05B | 640.55B | 560.76B | Total Assets |
2.09T | 2.09T | 1.93T | 1.77T | 1.54T | 1.39T | Total Debt |
13.25B | 13.07B | 12.19B | 11.54B | 10.79B | 11.52B | Net Debt |
-392.34B | -498.19B | -591.38B | -673.29B | -618.50B | -536.79B | Total Liabilities |
208.69B | 208.69B | 225.62B | 210.68B | 159.88B | 137.27B | Stockholders Equity |
1.88T | 1.88T | 1.70T | 1.56T | 1.38T | 1.25T |
Cash Flow | Free Cash Flow | ||||
35.08B | -6.10B | 27.24B | 75.16B | 91.18B | 85.63B | Operating Cash Flow |
35.08B | 98.21B | 101.62B | 156.09B | 120.47B | 124.61B | Investing Cash Flow |
0.00 | -131.90B | -87.09B | -116.22B | 73.44B | 24.92B | Financing Cash Flow |
0.00 | -87.93B | -113.30B | -88.93B | -56.01B | -49.92B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
73 Outperform | $10.06B | 22.50 | 16.15% | 1.71% | 0.78% | -8.42% | |
73 Outperform | $12.99B | 21.04 | 18.45% | 1.21% | -0.53% | 0.13% | |
72 Outperform | $22.10B | 20.43 | 8.42% | 1.43% | -6.85% | -20.37% | |
70 Outperform | $28.09B | 33.84 | 8.40% | 0.11% | 5.22% | 8.01% | |
69 Neutral | $25.68B | 28.26 | 26.22% | 2.25% | -11.28% | -23.69% | |
67 Neutral | $12.28B | 24.42 | 13.77% | 1.70% | -0.16% | -15.42% | |
62 Neutral | $7.24B | 12.39 | 3.08% | 3.39% | 3.63% | -14.35% |